Pharmaceutical Investing Rhythm Pharmaceuticals Announces Launch of TEMPO Registry for Rare Genetic Disorders of Obesity
Pharmaceutical Investing Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity
JZR Gold Inc. Announces Completion of Testing of Gravimetric Mill at the Vila Nova Gold Project in Brazil
China's Mineral Export Ban Reinforces Electric Royalties' Long-Term Strategic Focus on Projects Located in Safer Jurisdictions
